Spectrophotometer Suitability Using Blue Dye Standards
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for determining protein concentration using spectrophotometers are inconsistent and lack standardized system suitability criteria, leading to variability in measurement accuracy.
Innovation Solution
A method involving the use of Patent Blue dye (PBD) or AMG Blue dye at multiple wavelengths (280 nm, 310 nm, 412 nm, and 510 nm or 615 nm) to assess the suitability of variable and fixed path length spectrophotometers, with absorbance readings within 10% or 5% of the certificate of analysis and a relative standard deviation (RSD) of ≤ 5% as criteria for suitability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If spectrophotometers are used to determine protein concentration without standardized system suitability criteria, then measurement can be performed quickly, but measurement precision and reliability deteriorate due to inconsistency and variability
Solution Approach 1:
The patent implements preliminary system suitability testing using blue dye standards before actual protein concentration measurements. This preliminary action establishes instrument performance criteria (absorbance readings within 10% or 5% of certificate of analysis, RSD ≤ 5%) to ensure subsequent measurements will be reliable, resolving the contradiction by preparing the measurement system in advance rather than dealing with inconsistencies during actual measurement.
Solution Approach 2:
The patent changes the measurement parameter from direct protein concentration determination to blue dye absorbance measurement at multiple wavelengths (280 nm, 310 nm, 412 nm, 510 nm, or 615 nm). This parameter substitution allows indirect assessment of instrument suitability through well-established dye standards, improving measurement precision without requiring complex direct protein reference materials.
2Measurement precision
If multiple wavelengths are measured to assess instrument suitability, then measurement precision improves through more comprehensive evaluation, but loss of time increases due to multiple measurements
Solution Approach 1:
The patent applies partial action by selecting specific critical wavelengths (280 nm and 310 nm primarily, with optional 412 nm, 510 nm, or 615 nm) rather than measuring across the entire spectrum. This partial measurement approach provides sufficient instrument suitability assessment without the excessive time investment of comprehensive multi-wavelength scanning, resolving the contradiction between thoroughness and efficiency.
Solution Approach 2:
The patent performs wavelength selection and system suitability assessment as preliminary actions before actual protein measurements. By pre-establishing which wavelengths are necessary for instrument characterization and pre-validating instrument performance at these wavelengths, the time cost of multiple wavelength measurements is incurred once during setup rather than repeatedly during sample analysis.
3Reliability
If strict system suitability criteria (≤5% RSD, within 5-10% of certificate values) are enforced, then reliability of protein concentration determination improves, but productivity decreases due to additional validation steps
Solution Approach 1:
The patent enforces strict system suitability criteria (RSD ≤ 5%, absorbance within 10% or 5% of certificate of analysis) as preliminary validation steps before protein concentration measurements. By ensuring instrument reliability in advance through blue dye standard measurements, the actual protein analysis throughput is protected from rejections due to instrument drift, making the productivity loss during validation worthwhile for maintaining overall measurement reliability.
Solution Approach 2:
The patent implements feedback through system suitability testing that monitors instrument performance continuously. When blue dye absorbance readings fall outside acceptance criteria, the system provides feedback that protein measurements should not be performed until instrument performance is restored. This feedback loop ensures reliability without permanently reducing productivity, as measurements can proceed continuously once validation is established.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Ensures consistent and accurate protein concentration measurements by establishing precise system suitability criteria, enhancing the reliability and precision of protein concentration determination in therapeutic proteins.
Implementation Method 1
measuring the absorbance of Patent Blue dye (PBD) or AMG Blue Dye (ABD) at least two wavelengths, the first wavelength of 280 nm and the subsequent wavelength(s) selected from the group consisting of 310 nm, 412 nm, 510 nm and 615 nm
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Disclosed are methods of determining the suitability of a variable-length spectrophotometer using Patent Blue dye or AMG Blue dye. Also disclosed herein are methods of determining the suitability of a fixed path length spectrophotometer for determining protein concentration of a protein sample. AMG Blue dye may also be used to determine the suitability of fixed path length spectrophotometers.